Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy. - Suppr | 超能文献

Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.

作者信息

Cope Jessica Michelle, Bushwitz Jennifer, An Guohua, Antigua Abigail, Patel Anjan, Zumberg Marc

出版信息

Ann Pharmacother. 2015 May;49(5):614-5. doi: 10.1177/1060028015571658.

DOI:10.1177/1060028015571658

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.

Ann Pharmacother. 2015 May;49(5):614-5. doi: 10.1177/1060028015571658.

2

Comment: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.

Ann Pharmacother. 2015 May;49(5):612-3. doi: 10.1177/1060028015571726.

3

Clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.在患有中度至重度肾功能损害或需要肾脏替代治疗的肾衰竭的重症患者中使用预防性磺达肝癸钠的临床经验。

Ann Pharmacother. 2015 Mar;49(3):270-7. doi: 10.1177/1060028014563325. Epub 2014 Dec 16.

4

Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study.确定依诺肝素预防在重症且伴有严重肾功能不全患者中的安全性——PACER初步研究

Thromb Res. 2016 Aug;144:69-71. doi: 10.1016/j.thromres.2016.05.026. Epub 2016 Jun 2.

5

Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels.使用抗因子 Xa 水平评估严重肾功能障碍的危重症患者中延长间隔的磺达肝素给药方案用于预防静脉血栓栓塞症。

Pharmacotherapy. 2017 Oct;37(10):1241-1248. doi: 10.1002/phar.2014.

6

A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.一项在危重症成人中连续肾脏替代治疗时局部枸橼酸抗凝与局部肝素抗凝的随机对照试验。

Crit Care Med. 2015 Aug;43(8):1622-9. doi: 10.1097/CCM.0000000000001004.

7

Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.低剂量磺达肝癸钠用于危重症患者疑似肝素诱导的血小板减少症

Neth J Med. 2007 Mar;65(3):101-8.

8

Renal replacement therapy in the end-stage renal disease patient with critical illness.危重病终末期肾病患者的肾脏替代治疗。

Blood Purif. 2012;34(2):132-7. doi: 10.1159/000341727. Epub 2012 Oct 24.

9

Continuous Renal Replacement Therapy: Case Vignettes.连续性肾脏替代治疗：病例 vignettes。（注：vignettes 可译为“小插曲”“片段”等，这里结合语境可能是指病例片段之类的意思，整体译文可能稍显生硬，因为“vignettes”在医学语境中较难准确把握其含义，需结合更多原文内容来理解其确切意思。）

AACN Adv Crit Care. 2017 Spring;28(1):64-73. doi: 10.4037/aacnacc2017686.

10

Continuous renal replacement therapy in the critically ill patient.

Kidney Int. 2005 Jul;68(1):411-2. doi: 10.1111/j.1523-1755.2005.413_6.x.